Manju J Chaudhary
Overview
Explore the profile of Manju J Chaudhary including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kartik S, Pal R, Chaudhary M, Nath R, Kumar M
Ann Neurosci
. 2025 Jan;
31(4):265-276.
PMID: 39840143
Background: Parkinson's disease (PD) is characterized by dopaminergic (DA) neuron loss, Lewy body build-up, and motor dysfunction. One of the primary pathogenic mechanisms of PD development is autophagy dysfunction and...
2.
Tiwari P, Chaudhary M, Pal R, Nath R
Ann Neurosci
. 2024 Aug;
31(3):186-203.
PMID: 39156628
Background: Parkinson's disease (PD) is typified by inflammation of dopaminergic neurons leading to the release of various inflammatory mediators. These mediators activate the transcription factor NF-κB, which in turn activates...
3.
Tiwari P, Pal R, Chaudhary M, Nath R
Drug Dev Res
. 2023 Sep;
84(8):1652-1663.
PMID: 37712494
By harnessing artificial intelligence (AI) algorithms and machine learning techniques, the entire drug discovery process stands to undergo a profound transformation, offering a myriad of advantages. Foremost among these is...
4.
Kartik S, Pal R, Chaudhary M, Tiwari P, Nath R, Kumar M
Fundam Clin Pharmacol
. 2023 Feb;
37(4):794-806.
PMID: 36807936
Parkinson's disease (PD) is a neuromuscular ailment that affects people in their later years and causes both motor and non-motor deficits. Receptor-interacting protein-1 (RIP-1) is a critical participant in necroptotic...
5.
Kartik S, Pal R, Chaudhary M, Nath R, Kumar M, Binwal M, et al.
Inflammopharmacology
. 2023 Jan;
31(2):927-941.
PMID: 36715843
Parkinson's disease (PD) is a neuro-motor ailment that strikes adults in their older life and results in both motor and non-motor impairments. In neuronal and glial cells, PD has recently...
6.
Tiwari P, Chaudhary M, Pal R, Nath R
Fundam Clin Pharmacol
. 2022 Jul;
36(6):944-955.
PMID: 35853641
Nitric oxide (NO), generated by nitric oxide synthase enzymes (NOS), has an important role in maintaining synapse plasticity, neuro-modulation, and other physiological functions in the brain. NO thus generated also...
7.
Tiwari P, Chaudhary M, Pal R, Kartik S, Nath R
Ann Neurosci
. 2022 Mar;
28(3-4):137-149.
PMID: 35341236
Background: Parkinson's disease is a neurodegenerative disorder and is marked by inflammation and death of neurons in the striatum region of the midbrain. It has been reported that expression of...
8.
Pal R, Chaudhary M, Tiwari P, Nath R, Pant K
Inflammopharmacology
. 2018 Jun;
PMID: 29934863
Current study was designed to evaluate protective effect of mangiferin and its interaction with low dose of nitric oxide (NO) modulators in complete Freund's adjuvant (CFA) inoculated rats. Male wistar...
9.
Pal R, Chaudhary M, Tiwari P, Nath R, Babu S, Pant K
Inflammopharmacology
. 2016 Sep;
24(5):221-231.
PMID: 27671331
Aim: Present study was designed to evaluate protective effects of pentoxifylline and its potentiation with low dose of nitric oxide (NO) modulators in adjuvant-induced experimental arthritis in rats. Method: Wistar...
10.
Pal R, Chaudhary M, Tiwari P, Babu S, Pant K
Int Immunopharmacol
. 2015 Sep;
29(2):854-862.
PMID: 26349791
Theophylline (non-specific PDE inhibitor) and their interactions with nitric oxide modulators were evaluated in adjuvant-induced arthritic model of rats. Wistar rats (200-300g), 8 animals per group were used in the...